Bogart Wealth LLC’s TherapeuticsMD TXMD Stock Holding History

Bogart Wealth LLC’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4	Hold	2	–	–	﹤0.01%	2003
2026 Q1	$4	Buy	+2	New	+$4	﹤0.01%	1814

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bogart Wealth LLC's TXMD Position: Q2 2026 in Review

Bogart Wealth LLC held its TherapeuticsMD (TXMD) position steady in Q2 2026 at 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Bogart Wealth LLC first reported a position in TXMD in Q1 2026 and has held it in 2 quarters since. 44 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

Bogart Wealth LLC held 2 shares of TherapeuticsMD worth $4 as of Q2 2026.
Bogart Wealth LLC left its TherapeuticsMD share count unchanged in Q2 2026.
TherapeuticsMD made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #2003 holding.
Bogart Wealth LLC first reported a position in TherapeuticsMD in Q1 2026 and has held it in 2 quarters since.
44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.